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ABSTRACT
Aims To examine non-medical use of prescription opioids (NMUPO) patterns during the transition from adolescence
to adulthood, and assess individual characteristics and other substance use behaviors associated with longitudinal
patterns of NMUPO. Design Nationally representative samples of high school seniors in the United States (wave 1:
modal age 18 years) were followed longitudinally across three biennial follow-up waves (waves 2, 3 and 4: modal
ages 19/20, 21/22 and 23/24 years). Setting Data were collected via self-administered questionnaires to high
school seniors and young adults. Participants The longitudinal sample consisted of 27 268 individuals in 30 cohorts
(high school senior years 1976–2005) who participated in all four waves. Measurements Self-reports of NMUPO
and other substance use behaviors. Findings Approximately 11.6% [95% confidence interval (CI) = 11.2%, 12.0%]
of the sample reported past-year NMUPO in at least one of the four waves. Among those who reported past-
year NMUPO in at least one wave, 69.0% (67.6%, 70.4%), 20.5% (19.3%, 21.7%), 7.8% (7.1%, 8.6%) and 2.7% (2.3%,
3.1%) reported NMUPO at one, two, three and four waves, respectively. Several wave 1 variables were associated with
greater odds of multiple waves of NMUPO and individuals who reported more waves of NMUPO had greater odds
of other substance use behaviors. Conclusions Although most non-medical use of prescription opioids among
18-year-olds in the United States appears to be non-continuing, approximately one-third of the sample reporting
non-medical use of prescription opioids appear to continue use beyond age 18 and have elevated odds of other
substance use behaviors at ages 23/24.
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INTRODUCTION
The rates of medical and non-medical use of prescription
opioids (NMUPO) have been rising steadily over the past
15–20 years in the United States [1–12]. Although the
United States represents less than 5% of the world’s
population, Americans consume 80% of the global opioid
supply, and 99% of the global hydrocodone supply [10].
While there are several national studies that examine the
extent of NMUPO in the United States, there is limited
information regarding this public health issue in other
developed countries. As a result, cross-national compari-
sons of NMUPO are difficult to ascertain at this time [12].
In the United States, NMUPO among adolescents and
young adults has increased significantly over the past two
decades and is most prevalent among individuals 18–25
years of age [1–7]. In 2010, approximately 2 million
people aged 12 years or older initiated NMUPO within the
past 12 months, which was greater than the estimated
number of those who initiated use of any other illicit
drug with the exception of marijuana [7]. The estimated
number of emergency department visits involving
NMUPO more than doubled between 2004 and 2008
for patients younger than 21 years of age [8]. Although
there have been recent advances in the understanding of
NMUPO, considerable gaps in knowledge remain due to
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limitations in measures and study designs [9–12]. In par-
ticular, there are few longitudinal studies, leaving gaps
in our understanding of individual patterns of NMUPO
over time and of risk factors that identify accurately
those individuals at greatest risk for chronic patterns of
NMUPO [11].
To date, most large-scale national epidemiological
studies have been cross-sectional and have revealed high
levels of NMUPO with past-year prevalence rates as high
as 10% among secondary school students and 20%
among college students in the United States [2,3,13,14].
The age at peak risk for initiating NMUPO is 16 years, and
the majority of NMUPO is initiated prior to the age of 18
among early and middle-aged adults [2,3,15]. The
limited longitudinal evidence suggests that most NMUPO
is experimental, but that earlier use sets the stage for later
substance use disorders [16]. Based on the National Epi-
demiologic Survey on Alcohol and Related Conditions,
approximately four in every five adults aged 18 years or
older in the United States who engaged in NMUPO ceased
using 3 years later, but that NMUPO among 18–24-year-
olds was associated with greater odds of developing a
substance use disorder 3 years later [16]. Furthermore, a
cross-sectional study found that the initiation of NMUPO
before 18 years of age was associated with significantly
higher odds of developing prescription opioid abuse and
dependence versus those individuals who began using at
or after 18 years of age [17]. Indeed, more than 40% of
individuals in the United States who retrospectively
reported initiating NMUPO at age 18 or younger devel-
oped prescription drug use disorders in their life-time
[17]. Taken together, these results indicate that NMUPO
during the transition from adolescence to adulthood war-
rants longitudinal examination to distinguish experimen-
tal from escalating use.
Much attention has been devoted to the identification
of longitudinal patterns of alcohol and marijuana use
across the transition to adulthood [18–20]; similar atten-
tion has not been given to NMUPO. In addition, although
several cross-sectional studies have found strong associa-
tions between NMUPO and other substance use behaviors
[13,14,21,22], none have considered how NMUPO
relates to other substance use over time. To fill these criti-
cal gaps in current knowledge, our purpose is to be the
first national study to describe longitudinal patterns of
NMUPO during the transition to adulthood, to assess
demographic and individual characteristics associated
with these patterns of NMUPO and to examine other sub-
stance use behaviors associated with patterns of NMUPO.
We analyze national panel data from the Monitoring the
Future (MTF) study [2,3] and provide a more comprehen-
sive understanding of the heterogeneity associated with
NMUPO and its developmental course among adolescents
as they move into adulthood.
METHODS
The present study used national panel data from the MTF
study conducted in the United States [3,23]. Based on
a three-stage sampling procedure, MTF has surveyed
nationally representative samples of approximately
17 000 high school seniors each year since 1975, using
questionnaires administered in classrooms. Stage 1 is the
selection of geographic areas; stage 2 is the selection of
schools; and stage 3 is the selection of students within
each school. Approximately 2400 high school seniors are
selected for biennial follow-ups each year using mailed
questionnaires. The biennial follow-up surveys begin 1
year after high school for one random half of each cohort
and 2 years after high school for the other half. For the
purpose of these analyses, the two halves were combined
(combining modal ages 19/20, 21/22 and 23/24 years)
due to sample size concerns and lack of significant differ-
ences across the two halves on substance use measures.
Individuals who used illicit drugs in high school were
oversampled for the follow-up surveys. Corrective weight-
ing was used in the analyses to adjust for the unequal
probabilities of selection that occurred at any stage of
sampling. The project design and sampling methods are
described in greater detail elsewhere [3,24].
Sample
The sample for the present study consisted of respondents
who were surveyed as high school seniors (wave 1) from
1976 to 2005, and who were surveyed in their first,
second and third biennial follow-up surveys (waves 2, 3
and 4, respectively). Given the aims of the present study,
the 30 cohorts were combined and analyses were con-
ducted with 27 268 respondents (weighted number in
longitudinal sample) who provided data at all four waves,
yielding a retention rate of just under 50%. Relaxing this
requirement and imputing missing data would have
increased our longitudinal sample, but given our focus on
individual developmental patterns of NMUPO this full-
data inclusion criterion was necessary. This longitudinal
sample consisted of 59% females, 82% whites, 7% blacks,
5% Hispanics and 6% other racial/ethnic groups or not
specified. As illustrated in Table 1, attrition analyses at
wave 1 revealed that those retained in the longitudinal
sample differed compared to those who attrited. For
instance, individuals retained in the longitudinal sample
were more likely to be female and white, report good
grades in high school, have higher parent education,
have any college plans and have lower rates of skipping
class, evenings out, 2-week binge drinking and past-year
marijuana use. In addition, individuals retained in the
longitudinal sample had lower rates of past-year NMUPO
and past-year non-medical use of amphetamines and/or
tranquilizers.
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Measures
Using six randomly distributed questionnaire forms, the
MTF assesses demographic and psychosocial characteris-
tics and standard measures of substance use.
NMUPO
NMUPO was assessed at all four waves with an item
asking respondents on how many occasions (if any) they
had used prescription opioids on their own, without a
doctor’s orders (e.g. Vicodin®, OxyContin®, Percodan®,
Percocet®, Demerol®, Dilaudid®, morphine, metha-
done, opium, codeine), during the past 12 months. The
response scale was (1) no occasions, (2) one to two occa-
sions, (3) three to five occasions, (4) six to nine occasions,
(5) 10–19 occasions, (6) 20–39 occasions and (7)
40 or more occasions. It should be noted that the
list of examples was updated in 2002 and several
‘older’ medications (e.g. laudanum, Talwin®) were
replaced with more ‘current’ medications (e.g. Vicodin®,
OxyContin®, Percodan®, Percocet®, Dilaudid®). The
addition of these new examples was followed by an uptick
in prevalence of NMUPO, probably due in part to the
changed question [2,3].
Demographic and life-style characteristics
Demographic and life-style characteristics were assessed
at wave 1 and consisted of student self-reports of the
following: gender, race/ethnicity (black, white, Hispanic,
other), urbanicity (where grew up, farm/country versus
not), parental education (some college versus high school
or less), high school grade point average (B– or higher
versus C+ or lower), college plans (any plans versus no
plans), truancy (did not skip any days in the past 4 weeks
versus one or more skipped days), work intensity (no
work versus 1–15 hours per week versus 16 or more
hours per week), social evenings out (fewer than three per
week versus three or more per week), past 2-week binge
drinking (any versus none) and past-year marijuana use
(any versus none). Geographic region of the country
(Northeast, Midwest, South, West) was based on school
location information. Senior year cohort was split into
three periods based on the high school class survey
year (1976–91, 1992–2001 and 2002–05). These three
cohort periods were selected due to decreases in the
prevalence of NMUPO among high school seniors follow-
ing 1991 and a change in wording for the NMUPO
measure in 2002, resulting in an increase in the preva-
lence of NMUPO [2,3]. Cut-points in the covariates were
determined based on sensitivity analyses; categorical
covariates were desirable given our analytical and
descriptive approaches.
Other substance use behaviors
Other substance use behaviors were assessed at wave 4,
including 2-week binge drinking (any versus none) and
past-year marijuana use (any versus none). We also
included past-year other non-medical prescription
drug use—including amphetamines (e.g. Ritalin®,
Table 1 Wave 1 sample characteristics for the longitudinal
sample and attrition sample.
Longitudinal sample Attrition sample
n = 27 268 n = 27 862
% (95% CI) % (95% CI)
Gender
Male 40.7 (40.0–41.4) 54.6 (53.9–55.3)
Female 59.3 (58.6–60.0) 45.4 (44.7–46.1)
Race/ethnicity
Black 7.4 (6.6–8.1) 16.5 (15.1–17.9)
White 82.1 (81.0–83.1) 65.4 (63.7–67.1)
Hispanic 4.9 (4.4–5.5) 10.0 (8.9–11.1)
Other 5.6 (5.2–6.0) 8.1 (7.7–8.5)
Geographical region
South 30.2 (28.6–31.7) 37.2 (35.7–38.8)
Northeast 21.7 (20.3–23.1) 19.7 (18.5–20.8)
Midwest 31.3 (29.7–32.9) 23.9 (22.6–25.2)
West 16.8 (15.5–18.1) 19.2 (17.9–20.6)
Urbanicity
Farm/country 19.2 (18.1–20.3) 17.1 (16.2–18.0)
Small city or larger 80.8 (79.7–81.9) 82.9 (82.0–83.8)
Parent education
Some college 65.2 (64.1–66.3) 62.5 (61.5–63.6)
High school or less 34.8 (33.7–35.9) 37.5 (36.4–38.5)
High school GPA
B– or higher 82.8 (82.2–83.4) 70.7 (69.9–71.5)
C+ or lower 17.2 (16.6–17.8) 29.3 (28.5–30.1)
College plans
Yes college plans 51.7 (50.6–52.8) 44.7 (43.7–45.7)
No college plans 48.3 (47.2–49.4) 55.3 (54.3–56.3)
Truancy
Did not skip any days 68.4 (67.4–69.3) 60.8 (59.8–61.8)
Skipped any days 31.6 (30.7–32.6) 39.2 (38.2–40.2)
Work intensity
No work 22.5 (21.8–23.1) 24.9 (24.2–25.6)
1–15 hours/week 33.6 (33.0–34.3) 26.5 (25.9–27.1)
16+ hours/week 43.9 (43.1–44.7) 48.6 (47.8–49.4)
Evenings out
Less than 3 weekly 52.8 (52.1–53.5) 48.6 (47.8–49.3)
3 or more weekly 47.2 (46.5–47.9) 51.4 (50.7–52.2)
Binge drinking
No, past 2 weeks 70.5 (69.7–71.3) 64.7 (63.9–65.5)
Yes, past 2 weeks 29.5 (28.7–30.3) 35.3 (34.4–36.1)
Marijuana use
No, past 12 months 68.4 (67.6–69.3) 60.7 (59.9–61.5)
Yes, past 12 months 31.6 (30.7–32.4) 39.3 (38.5–40.1)
Senior year cohort
1976–91 60.0 (57.6–62.5) 42.2 (39.8–44.7)
1992–2001 30.9 (28.6–33.2) 42.0 (39.5–44.5)
2002–05 9.1 (7.8–10.3) 15.7 (13.8–17.7)
All frequencies and percentages are weighted. CI = confidence interval;
GPA = grade point average.
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Dexedrine®) and/or tranquilizers (e.g. Ativan®,
Klonopin®, Valium®, Xanax®)—which were measured
with the following questions: ‘On how many occasions (if
any) have you used [specified drug class] during the last
12 months?’. The response scale for each substance was
the same as for NMUPO. A single dichotomous variable
was created for analysis from the separate measures to
indicate prevalence of use for one or more of these drug
classes.
Data analysis
Given that this was the first national study to examine
longitudinal patterns of NMUPO systematically during
the transition from adolescence to adulthood, we took
a straightforward descriptive approach to addressing
our research questions. First, the patterns of past-year
NMUPO and the number of waves of past-year NMUPO
were described using simple frequency tables. Secondly,
multivariable logistic regression models were used to
examine the relationships of wave 1 demographics and
life-style characteristics with the following three patterns
of past-year NMUPO: (i) at one wave only, (ii) at two or
more waves and (iii) at all four waves. These three pat-
terns of NMUPO were chosen to capture experimental
use at one wave only, repeated use at two or more waves
and chronic use at all four waves. Finally, we examined
the prevalence of wave 4 substance use behaviors
(i.e. binge drinking in the past 2 weeks, marijuana use
in the past year and other non-medical use of prescrip-
tion drugs in the past year) by the number of waves of
NMUPO (i.e. no waves, one, two, three and four waves).
Multivariable logistic regression models were used con-
trolling for wave 1 demographic and life-style character-
istics to understand the unique contribution of NMUPO
patterns to wave 4 substance use behaviors. Analyses
incorporated the complex sample design variables and
were weighted for follow-up sampling selection using
SAS version 9.3 SURVEY commands (MEANS, FREQ,
LOGISTIC, REG) as appropriate.
RESULTS
Approximately 11.6% (95% CI = 11.2%, 12.0%) of the
sample reported past-year NMUPO in at least one of the
four waves of measurement. The mean level of occasions
of past-year NMUPO in the sample held relatively steady
over the four waves. The weighted mean frequency of
past-year NMUPO (response scale ranged from 1, ‘no
occasions’ to 7, ‘40 or more occasions’) was 1.09 at wave
1 (modal age 18) and 1.08 at waves 2, 3 and 4 (modal
ages 19/20, 21/22 and 23/24 years, respectively). As
shown in Table 2, there were 16 possible patterns of past-
year NMUPO over time. The majority of high school
seniors who reported past-year NMUPO at wave 1 did not
engage in this behavior again at waves 2, 3 or 4.
In the second phase of the analyses, multivariable
logistic regression analyses indicated that several wave
1 variables, including race/ethnicity (white), truancy,
binge drinking, marijuana use and senior year cohorts
after 1991, were associated with significantly greater
odds of all three patterns of past-year NMUPO (see
Table 3). For example, the odds of past-year NMUPO at
two or more waves were more than six times greater
among high school seniors who reported past-year mari-
juana use at wave 1 compared to those who did not
use marijuana. Other covariates were related less con-
sistently to NMUPO patterns. High school seniors who
reported ‘other’ race/ethnicity and those who spent three
or more evenings out per week had greater odds of past-
year NMUPO at one wave only and at two or more waves.
High school seniors with at least one college educated
parent had greater odds of past-year NMUPO at two or
more waves and at all four waves. Those who had lower
grade point averages and reported being Hispanic had
greater odds of past-year NMUPO at one wave only while
high school males had greater odds of past-year NMUPO
at two or more waves. High school seniors without plans
to attend college had greater odds of past-year NMUPO
at all four waves. Finally, urbanicity and work intensity
were not associated with any of the three patterns of
NMUPO.
In the third phase of the analyses, we examined the
wave 4 (modal ages 23/24) prevalence rates of binge
drinking in the past 2 weeks, marijuana use in the past
year and other non-medical use of prescription drugs in
the past year as a function of the number of waves of
NMUPO and wave 1 covariates from phase 2 of the analy-
ses. As shown in Table 4, binge drinking was the most
common substance use behavior among those who never
engaged in past-year NMUPO, whereas past-year mari-
juana use was the most common substance use behavior
among those who reported any past-year NMUPO over
four waves. Substance use behaviors at wave 4 were
more prevalent among those who reported more waves of
past-year NMUPO.
As presented in Table 4, multivariable logistic regres-
sion analyses confirmed that substance use behaviors
at wave 4 were highly associated with number of waves
of past-year NMUPO after adjusting for covariates. The
odds of substance use behaviors at wave 4 were signifi-
cantly greater among those who reported more waves
of NMUPO compared to those who never engaged in
NMUPO. Notably, individuals who reported NMUPO at all
four waves had approximately four times greater odds of
binge drinking in the past 2 weeks, approximately 17
times greater odds of marijuana use in the past year and
approximately 39 times greater odds of non-medical use
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of other prescription drugs in the past year than those
who had not reported NMUPO at any of the four waves.
DISCUSSION
The findings of the present study extend what is known
about the longitudinal patterns of NMUPO among ado-
lescents during the transition to adulthood in several
important ways. Sixteen different longitudinal patterns
associated with NMUPO were described, and the most
prevalent pattern of use included those who reported
NMUPO only in their senior year of high school. The
majority of individuals who reported NMUPO in their
senior year of high school did not engage in this behavior
1–2 years later and even fewer reported NMUPO 3–6
years later. The results of this study were consistent with
a previous study that found the majority of adults (18
years or older) who engaged in NMUPO in the United
States ceased using 3 years later [16]. Thus, the present
study represents an important first step towards under-
standing the heterogeneity and persistence associated
with NMUPO from a longitudinal perspective.
Multivariable logistic regression analyses identified
several common wave 1 variables that were associated
with significantly greater odds of engaging in multiple
waves of past-year NMUPO including race/ethnicity
(white), truancy, binge drinking, marijuana use and
more recent high school senior year cohorts (1992–
2005). The findings of the present study indicated that
white adolescents and those who engaged in multiple
problem behaviors while in high school were at increased
risk for more chronic patterns of NMUPO during the
transition to adulthood. The results also provided addi-
tional support for a significant increase in NMUPO
among adolescents and young adults over the past two
decades [1–3,5,6]. Based on the recent increases in
prevalence of NMUPO in the United States, additional
prevention and intervention efforts are clearly warranted
to reduce NMUPO among adolescents and young adults.
We found significant associations between longitudi-
nal patterns of NMUPO and other substance use
behaviors, such as binge drinking, marijuana use and
non-medical use of other prescription drugs. While only
about 3% of non-medical users reported NMUPO at
all four waves, nearly all these individuals reported
other substance use behaviors at ages 23/24. The odds
of substance use behaviors were significantly greater
among individuals who reported more waves of past-year
Table 2 Frequencies and patterns associated with non-medical use of prescription opioids over four waves.
Past-year non-medical use
of prescription opioids
Number of
waves
Frequency
(n)
Overall sample (%)
(95% CI)
Non-medical users
(n = 3173) (%)
(95% CI)
No waves 0 24 096 88.4 (88.0–88.7) –
Wave 1 only 1 733 2.7 (2.5–2.8) 23.1 (22.0–24.3)
Wave 2 only 1 487 1.8 (1.6–1.9) 15.3 (14.2–16.5)
Wave 3 only 1 493 1.8 (1.7–2.0) 15.5 (14.4–16.7)
Wave 4 only 1 477 1.7 (1.6–1.9) 15.0 (13.8–16.2)
Waves 1 and 2 2 165 0.6 (0.5–0.7) 5.2 (4.6–5.8)
Waves 1 and 3 2 72 0.3 (0.2–0.3) 2.3 (1.9–2.7)
Waves 1 and 4 2 67 0.3 (0.2–0.3) 2.2 (1.8–2.5)
Waves 2 and 3 2 97 0.4 (0.3–0.4) 3.1 (2.5–3.6)
Waves 2 and 4 2 68 0.3 (0.2–0.3) 2.2 (1.7–2.6)
Waves 3 and 4 2 179 0.7 (0.6–0.7) 5.6 (4.9–6.4)
Waves 1, 2 and 3 3 76 0.3 (0.2–0.3) 2.4 (2.0–2.8)
Waves 1, 2 and 4 3 44 0.2 (0.1–0.2) 1.4 (1.1–1.7)
Waves 1, 3 and 4 3 42 0.2 (0.1–0.2) 1.3 (1.0–1.6)
Waves 2, 3 and 4 3 87 0.3 (0.3–0.4) 2.8 (2.2–3.3)
All four waves 4 84 0.3 (0.3–0.4) 2.7 (2.3–3.1)
Total – 27 268
Number of waves
No waves 24 096 88.4 (88.0–88.7) –
One wave 2 189 8.0 (7.7–8.3) 69.0 (67.6–70.4)
Two waves 650 2.4 (2.2–2.5) 20.5 (19.3–21.7)
Three waves 249 0.9 (0.8–1.0) 7.8 (7.1–8.6)
Four waves 84 0.3 (0.3–0.4) 2.7 (2.3–3.1)
Total 27 268
All frequencies and percentages are weighted. CI = confidence interval.
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NMUPO, and these high rates did not decline at ages
23/24 as they do typically for these substance use
behaviors as adolescents transition to adulthood [3,25–
27].
High school graduation represents a major develop-
mental transition for many adolescents in the United
States. Adolescents and young adults often assume
responsibility for their own medication management
during the transition to adulthood, which may contribute
to the high rates of NMUPO found in this age group
[2–4,7]. Past work has found that the majority of adoles-
cents and young adults who report NMUPO obtain
Table 3 Logistic regression results for selected non-medical use of prescription opioids patterns.
Wave 1 characteristics
Non-medical use at one wave only Non-medical use at two or more waves Non-medical use at all four waves
(%) Adjusted OR (95% CI) (%) Adjusted OR (95% CI) (%) Adjusted OR (95% CI)
Gender
Male 8.6 Referent 4.4 Referent 0.1 Referent
Female 7.7 1.00 (0.91,1.09) 3.1 0.79 (0.70,0.89)** 0.2 0.75 (0.55,1.03)
Race/ethnicity
Black 3.2 Referent 1.1 Referent 0.0 Referent
White 8.7 2.26 (1.73,2.95)*** 3.9 2.46 (1.57,3.84)*** 0.2 9.34 (1.26,69.19)*
Hispanic 6.0 1.59 (1.11,2.27)* 2.4 1.34 (0.76,2.33) 0.1 3.86 (0.45,33.42)
Other 5.8 1.78 (1.28,2.47)** 3.0 2.07 (1.21,3.55)** 0.0 1.96 (0.20,19.56)
Geographical region
South 7.4 Referent 3.2 Referent 0.1 Referent
Northeast 8.2 0.87 (0.78,0.98)* 4.0 0.98 (0.82,1.17) 0.2 0.72 (0.45,1.16)
Midwest 7.9 0.88 (0.79,0.98)* 3.4 0.90 (0.76,1.05) 0.2 0.68 (0.45,1.04)
West 9.0 1.07 (0.93,1.24) 4.2 1.08 (0.89,1.33) 0.2 1.06 (0.67,1.70)
Urbanicity
Farm/country 6.8 Referent 2.8 Referent 0.1 Referent
Small city or larger 8.3 1.07 (0.95,1.20) 3.8 1.00 (0.85,1.17) 0.2 1.29 (0.83,2.01)
Parental education
Some college 8.5 Referent 4.3 Referent 0.2 Referent
High school or less 7.2 0.92 (0.83,1.01) 2.4 0.67 (0.58,0.78)*** 0.1 0.59 (0.38,0.91)*
High school GPA
B- or higher 7.5 Referent 3.4 Referent 0.2 Referent
C+ or lower 10.4 1.18 (1.05,1.32)** 4.6 1.08 (0.94,1.25) 0.2 1.17 (0.78,1.74)
College plans
Yes college plans 7.6 Referent 3.5 Referent 0.1 Referent
No college plans 8.6 1.03 (0.93,1.14) 3.8 1.13 (0.99,1.29) 0.2 1.80 (1.27,2.55)**
Truancy
Did not skip any days 6.5 Referent 2.3 Referent 0.1 Referent
Skipped any days 11.5 1.24 (1.13,1.37)*** 6.4 1.64 (1.44,1.86)*** 0.3 1.68 (1.17,2.40)**
Work intensity
No work 7.0 Referent 3.1 Referent 0.1 Referent
1–15 hours/week 7.4 0.96 (0.85,1.09) 3.2 0.91 (0.76,1.09) 0.2 1.24 (0.80,1.93)
16+ hours/week 9.0 1.04 (0.92,1.17) 4.1 0.98 (0.84,1.15) 0.2 1.14 (0.74,1.74)
Evenings out
Less than 3 weekly 6.1 Referent 2.1 Referent 0.1 Referent
3 or more weekly 10.1 1.17 (1.06,1.28)** 5.3 1.44 (1.26,1.64)*** 0.2 1.22 (0.86,1.74)
Binge drinking
No, past 2 weeks 5.8 Referent 2.0 Referent 0.1 Referent
Yes, past 2 weeks 13.6 1.32 (1.19,1.46)*** 7.6 1.70 (1.48,1.95)*** 0.4 2.44 (1.66,3.57)***
Marijuana use
No, past 12 months 4.1 Referent 1.1 Referent 0.0 Referent
Yes, past 12 months 16.3 3.62 (3.23,4.05)*** 9.1 6.30 (5.30,7.48)*** 0.4 13.07 (6.80,25.12)***
Senior year cohort
1976–91 7.6 Referent 2.7 Referent 0.1 Referent
1992–2001 8.0 1.29 (1.16,1.42)*** 4.1 2.17 (1.87,2.53)*** 0.2 3.12 (2.05,4.74)***
2002–05 11.0 1.88 (1.61,2.21)*** 8.0 4.88 (4.06,5.87)*** 0.4 9.71 (6.39,14.75)***
*P < 0.05; **P < 0.01; ***P < 0.001. OR = odds ratio; CI = confidence interval; GPA = grade point average. Referent indicates reference group.
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prescription opioids from their friends for free and more
than a third obtain them from their own leftover prescrip-
tion [2,7,28,29]. The present study found that more than
one in every nine individuals in the sample reported
past-year NMUPO in at least one of the four waves of
measurement. Although there is some evidence based on
the present study that the mean frequency of past-year
NMUPO held steady for the sample, the prevalence of
NMUPO for the sample was lower over time, suggesting
that those reporting NMUPO were using more frequently.
The lack of mean level change across the transition to
adulthood belies the underlying changes in individual
patterns, with the most common NMUPO pattern being
to use at only one wave, suggesting a strong proclivity
towards experimental use only.
The present investigation has several strengths that
build upon previous substance abuse research examining
NMUPO among adolescents and young adults. First, this
study includes nationally representative samples of high
school seniors in the United States. Secondly, multiple
cohorts of high school seniors were followed longitudi-
nally across four waves, enabling an assessment of
NMUPO over time and historical change. To date, most
national studies have been cross-sectional and have not
examined patterns of NMUPO by following adolescents
from a modal age of 18 to 24 years of age.
The present study also has some limitations that need
to be taken into account when considering the implica-
tions of the findings. First, the updates to the prescription
opioid category in 2002 may have contributed to the
associations between patterns of NMUPO and later
cohorts (2002–05). However, no such wording changes
were made between 1992 and 2001, and these cohorts
were also associated with significantly increased odds of
NMUPO, which argues for increases of NMUPO in later
cohorts. Changes in wording in longitudinal studies
always represent a challenge to tracking prescription
medications over time, and the updates in the 2002 ques-
tion make it undeniably more difficult to interpret the
trends. However, similar changes were made to prescrip-
tion medication questions in other national studies (e.g.
National Epidemiologic Survey on Alcohol and Related
Conditions, National Survey on Drug Use and Health,
College Alcohol Study) and, on balance, creating ques-
tions that include ‘current’ medications is more impor-
tant than maintaining items with obsolete wording. An
additional limitation is that the survey items did not
specify the quantity of prescription opioids that was used
on each occasion. Finally, retention over all four waves
was approximately 50%; males, non-whites and those
who reported NMUPO and other problem behaviors were
less likely to participate in the study over time based on
attrition analyses. Thus, it is very likely that individuals
who experienced the most serious patterns of and conse-
quences associated with NMUPO are under-represented
in the longitudinal sample, suggesting that our findings
represent an underestimation of high use patterns and
potential consequences.
Based on increases in NMUPO and prescribing of
opioids over the past two decades [30–32], future
research should examine the association between pre-
scribing patterns of prescription opioids and NMUPO
among adolescents and young adults. Based on the long-
term health risks associated with early initiation of
NMUPO, the prediction of future NMUPO during child-
hood and early adolescence represents an important
topic for future research [15,17]. Previous research has
shown that heavy drinking and other substance use
behaviors tend to decline as young adults assume
greater responsibilities [3,19,25–27]. An important
question for future research, based on the present find-
ings, is whether the typical decline in substance use
behaviors holds equally well for NMUPO based on the
high abuse potential of prescription opioids [32].
Table 4 Bivariate and logistic regression results for substance use behaviors associated with non-medical use of prescription opioids.
Number of waves of
non-medical use
Wave 4 binge drinking past 2 weeks Wave 4 past-year marijuana use
Wave 4 past-year other non-medical
prescription drug usea
% Adjusted OR (95% CI)b % Adjusted OR (95% CI)b % Adjusted OR (95% CI)b
No waves 33.1 Referent 22.5 Referent 6.0 Referent
One wave 52.9 1.99 (1.82,2.17)*** 55.8 3.88 (3.56,4.23)*** 26.3 5.14 (4.62,5.71)***
Two waves 61.6 2.59 (2.24,2.99)*** 71.1 7.71 (6.53,9.11)*** 45.1 12.05 (10.43,13.93)***
Three waves 72.2 3.61 (2.83,4.59)*** 84.8 16.14 (11.99,21.73)*** 56.4 18.51 (14.75,23.22)***
Four waves 73.3 4.10 (2.81,5.99)*** 85.7 17.83 (11.00,28.90)*** 71.8 39.24 (28.04,54.90)***
***P < 0.001. OR = odds ratio; CI = confidence interval. aOther non-medical prescription drug use included non-medical use of prescription ampheta-
mines and/or tranquilizers. bAOR indicates odds ratios are adjusted for the effects of gender, race/ethnicity, geographical region, parent education, high
school grade point average, college plans, truancy, evenings out and senior year cohort (odds ratios for these variables are not shown). Referent indicates
reference group.
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